A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)
about
Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment optionsMerkel Cell Carcinoma: Epidemiology, Target, and TherapyMutational analysis of merkel cell carcinomaSpecific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma.Activation of abl family kinases in solid tumors.Functions and uses of immunohistochemical stains in cutaneous infiltrates of hematopoietic origin: a review for the practicing dermatologist.Advances in Merkel cell carcinoma pathogenesis and management: a recently discovered virus, a new international consensus staging system and new diagnostic codes.Multidisciplinary management in Merkel cell carcinoma.Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinomaMerkel Cell Carcinoma: Current Issues Regarding Diagnosis, Management, and Emerging Treatment Strategies.Merkel cell carcinoma: Do you know your guidelines?Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma.Merkel Cell Carcinoma Therapeutic Update.Dramatic response of an inoperable Merkel cell carcinoma with imatinibMerkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment.Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?Merkel cell carcinoma: chemotherapy and emerging new therapeutic options.Molecular challenges of neuroendocrine tumors.Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.[Unusual cause of orbital mass].Significant overexpression of the Merkel cell polyomavirus (MCPyV) large T antigen in Merkel cell carcinoma.Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma.
P2860
Q26796421-680A1F76-49D1-496A-90C8-756EA3A77CBFQ26824521-E3EB864A-5068-426A-96E9-A8C1BF8F6C78Q27021034-90998D93-808A-441D-B183-6334685EE42AQ34690237-3DBF757F-F751-47A1-9447-0AEE372354B7Q35138259-4F785E42-4036-4D60-94BC-7E2A104416C9Q36443421-7A962F7A-7874-464B-8C31-8C8E33661277Q37863265-0CBCD421-938D-4BB1-9620-D8C7D2AD0B54Q37913459-0CA908A5-AF4F-41D0-A09E-CEE43282961FQ38065281-8E3DE48F-115C-4F4B-8C3A-47CB670F8D90Q38084205-E3C5E40B-00ED-4CC5-BE97-728373997F6DQ38644262-3DF5FCDF-4A62-4AF3-ADA5-B65F5FFDBF15Q38682926-E99254DF-D41F-4D87-86C6-745459D5D1C0Q38714104-E140EA2A-B4FF-455A-B589-DCBDB76291E5Q38855025-2E08BA2A-86F8-4954-B820-06C507F41FBCQ39559942-E50B915F-3C5A-42A7-A72C-175C1A07C24EQ40100093-AF7DB10D-1C42-4222-B192-A68A2672119EQ41458291-E7FA9553-F0A7-4C9C-8ECD-AC6CAE6E3DC6Q43239986-178F04AD-9523-46CD-B210-C8E8429CF1C2Q49875027-71D27B83-D8E1-4BF4-9752-ABBC33FEB1BAQ50060650-710DD2AF-E7AB-4CA1-B961-5E0B9D558041Q52875970-773516BC-A896-4F31-A786-B5AF6FD246F5Q53670028-DE0D8282-B7C9-47CF-8D58-3D13EF96FAD0Q54642656-7BBAE10D-D1D0-4AE7-A8B5-632F06FC8FD3
P2860
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A phase II trial of imatinib m ...... t Oncology Group study (S0331)
@ast
A phase II trial of imatinib m ...... t Oncology Group study (S0331)
@en
A phase II trial of imatinib mesylate in merkel cell carcinoma
@nl
type
label
A phase II trial of imatinib m ...... t Oncology Group study (S0331)
@ast
A phase II trial of imatinib m ...... t Oncology Group study (S0331)
@en
A phase II trial of imatinib mesylate in merkel cell carcinoma
@nl
prefLabel
A phase II trial of imatinib m ...... t Oncology Group study (S0331)
@ast
A phase II trial of imatinib m ...... t Oncology Group study (S0331)
@en
A phase II trial of imatinib mesylate in merkel cell carcinoma
@nl
P2093
P2860
P1476
A phase II trial of imatinib m ...... t Oncology Group study (S0331)
@en
P2093
James Moon
John A Thompson
Lawrence E Flaherty
Merle T Witter
Naomi S Balzer-Haas
Ralph J Tuthill
Ronald C DeConti
Stuart A Merl
Vernon K Sondak
P2860
P304
P356
10.1097/COC.0B013E3181B9CF04
P577
2010-10-01T00:00:00Z